Albumin and Associated Biomarkers in Severe Neuropsychiatric Disorders: Acute-Phase Schizophrenia and Bipolar Disorder
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index; 4 of the 24 sources its claims cite were checked for support.
Abstract
Background: Inflammation is relevant to the pathophysiology of severe neuropsychiatric disorders, schizophrenia (SCZ) and bipolar disorders (BD). Multiple pathophysiological biomarkers are valuable for the study of inflammatory processes. This study investigated albumin-related biomarkers in SCZ and BD to explore their roles in disease. Methods: A total of 5,577 SCZ, 3442 BD-manic (BD-M) and 1405 BD-depression (BD-D) in acute stage and 5000 health controls (HCs) were enrolled. The differences in these biomarker levels among different groups were compared, and the contributing factors for the occurrence of SCZ, BD, and subgroups of BD were analyzed. Results: Both SCZ and BD exhibit lower prognostic nutritional index (PNI), but higher neutrophil percentage-to-albumin ratio (NPAR) and creatinine-albumin ratio (CRA) compared with HC. Compared with BD-D, BD-M had higher NPAR and platelet-to-albumin ratio (PAR) and lower CRA. In logistic regression, lower prognostic nutritional index (PNI) and higher CRA were associated with both SCZ and BD, while higher NPAR was associated with BD. In the subgroup of BD, higher NPAR, CRA and lower PNI were associated with BD-M; lower PAR, PNI and higher CRA were associated with BD-D. Conclusion: Our study reaffirmed the role of inflammation in the pathophysiology of SCZ and BD. Diagnostic value has been demonstrated in NPAR, PAR, PNI and CRA for BD and SCZ.
Overview
CoChat Summary
TL;DR
In a large retrospective study, acute schizophrenia (SCZ) and bipolar disorder (BD) patients showed lower albumin and prognostic nutritional index (PNI) but higher neutrophil percentage-to-albumin ratio (NPAR) and creatinine–albumin ratio (CRA) than healthy controls. Albumin-related ratios were associated with disease occurrence, with PNI protective and CRA a risk factor for both SCZ and BD.
Key findings
- Compared with 5,000 healthy controls, both SCZ (n=5,577) and BD (n=4,847) had lower PNI and higher NPAR and CRA after adjusting for age and sex (e.g., PNI F=768.43, P=0.000; NPAR F=318.60, P=0.000; CRA F=410.66, P=0.000).
- BD-manic (BD-M; n=3,442) had higher NPAR and platelet-to-albumin ratio (PAR) and lower CRA than BD-depression (BD-D; n=1,405). BD-D had lower PAR than both healthy controls and SCZ, and higher NPAR and CRA than SCZ.
- In logistic regression, lower PNI and higher CRA were associated with both SCZ and BD; higher NPAR was associated with BD. For SCZ, PNI β=−0.183 and CRA β=1.657; for BD, NPAR β=0.370, PNI β=−0.118, and CRA β=1.849.
- In BD subgroups, higher NPAR, higher CRA, and lower PNI were associated with BD-M; lower PAR, lower PNI, and higher CRA were associated with BD-D (BD-D: PAR β=−0.126, PNI β=−0.148, CRA β=2.031).
Methods
- Retrospective cross-sectional/case–control study using electronic medical records from Beijing Hui-Long-Guan Hospital from March 15, 2015 to March 15, 2021.
- Enrolled 5,577 SCZ, 3,442 BD-M, 1,405 BD-D, and 5,000 healthy controls; Han Chinese, aged 18–65, diagnosed by ICD-10 criteria, with exclusions for comorbid psychiatric disorders, inflammatory/immune/antioxidant-affecting somatic diseases, pregnancy/lactation, BMI >29.9 or <18.5 kg/m², heavy smoking, and hepatopathy/nephropathy/anemia.
- ANCOVA with age and sex as covariates and Bonferroni post hoc tests compared biomarkers; binary logistic regression adjusted for age and sex assessed risk factors, with nomograms combining multiple indicators.
Limitations
- The paper states that as a retrospective study, certain clinical information was absent, including course of disease, first episode of psychosis, BMI, and disease severity.
- The paper states that the cross-sectional design lacks causal conclusions between albumin-related parameters and BD or SCZ.
- The paper states that dietary supplementation and pharmacotherapy information was unreliable and fragmented, so these confounding factors could not be assessed; evident from the text, the study was also single-center and based on acutely admitted inpatients, which may limit generalizability.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
3 Valid · 0 Not valid · 14 Not checked · 44 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“Previous studies demonstrated that multiple pathophysiological biomarkers, which are easily available by use of routine blood examinations, are valuable for the study of inflammatory processes and immune states in psychiatry.5,6”
§ Albumin and Associated Biomarkers in Severe Neuropsychiatric Disorders: Acute-Phase Schizophrenia and Bipolar Disorder > Introduction
What the sources say
- Supportedcites [5] Xu, 2022, Front Psychiatry source
The Introduction (our copy) states that 'Complete blood counts and UCB are biomarkers that can be obtained quickly in routine blood tests' and that PLR, NLR, MLR and RDW 'are reproducible biomarkers of inflammation and calculated from the complete blood count, and its pathogenetic role has been investigated in schizophrenia'. The Discussion adds that 'NLR, MLR, and PLR are convenient markers of the systemic inflammatory response... and provide more stable information than other single leukocyte parameters', and the paper's Results/Conclusion show these leukocyte- and CBC-derived indices (total WBC, neutrophils, lymphocytes, monocytes, MPV, RDW) used as predictors of acute schizophrenia (AUC 0.831). This covers the attributed content — several biomarkers obtainable from routine blood tests being useful for studying inflammatory/immune-cell parameters in a psychiatric disorder — with the source's evidence base being schizophrenia rather than psychiatry generally, which the surrounding citations share. (LLM, conf=0.82)
- Supportedcites [6] Balcioglu, 2020, Psychiatry Investig source
The INTRODUCTION (p. 1) states that peripheral biomarkers of inflammation derived from complete blood counts 'have been investigated in numerous studies in recent years' and that NLR, PLR, MLR, RDW and MPV 'are inexpensive and reproducible biomarkers of inflammation and easily measured in a CBC,' with elevated levels shown in both mood disorders and schizophrenia — matching 'multiple biomarkers easily available by routine blood examinations.' The DISCUSSION adds that 'CRP and albumin screening are readily available, usually within minutes of acute admission, and are often performed automatically as part of an admission profile,' and the paper frames these markers as informative about inflammatory/immune state versus trait in psychiatric illness ('many neuropsychiatric diseases,' trait- vs state-relatedness). This is a broad background statement and our copy plainly treats the topic that way. (LLM, conf=0.85)
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Over the last two decades, chronic systemic inflammation and immunity are relevant to the pathophysiology of SCZ3 and BD.4”
§ Albumin and Associated Biomarkers in Severe Neuropsychiatric Disorders: Acute-Phase Schizophrenia and Bipolar Disorder > Introduction
What the sources say
- Not checked yetcites [3] Morris, 2021, Neurosci Biobehav Rev source
- Partly supportedcites [4] Jones, 2020, BJPsych Open sourceExperimental — accuracy not yet measured
Our copy supports the bipolar-disorder half: the Abstract's Aims and the Immunopsychiatry section frame the review as summarising 'emerging pathophysiological models' of the inflammatory response system 'for both MDD and bipolar disorders', and the Results (p. 3-4) report elevated peripheral cytokines/CRP and post-mortem neuroinflammation evidence in bipolar disorders. However, the schizophrenia half of the claim is not in our copy: the review is explicitly restricted to mood disorders (MDD and bipolar disorders), and 'schizophrenia' appears only inside a cited reference title (Ayerbe et al. 2018, on hypertension risk and clinical care) used for inflammation-associated metabolic comorbidity, not for SCZ pathophysiology. Additionally, the source hedges throughout ('putative pathophysiological association', 'an activated inflammatory response may be associated with a mood state', 'there is conflicting evidence on whether this link is causal'), whereas the citing sentence states relevance to pathophysiology as settled fact. (LLM, conf=0.82)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“However, for complicated diseases, like a lot of physical diseases and psychotic illnesses, one single biological marker often could not display satisfactory predictive value, while combined biomarkers can effectively improve the sensitivity of prediction.7”
§ Albumin and Associated Biomarkers in Severe Neuropsychiatric Disorders: Acute-Phase Schizophrenia and Bipolar Disorder > Introduction
What the sources say
- Partly supportedcites [7] Zhao, 2020, BMC Surg sourceExperimental — accuracy not yet measured
The Background (para. 1) of our copy states almost exactly the attributed point: 'While their predictive value is unsatisfactory when used alone, their use, in combination, can effectively improve the sensitivity of prediction', and the Discussion opens 'In complicated disease like AP, a single biomarker usually could not provide accurate prognostic effect... more and more combinations of biomarkers were being applied recently.' However, both statements are bounded to acute pancreatitis and the CRP/Cr/Alb-based markers (with the combination point itself credited in our copy to Yang et al. [13]); our copy says nothing about 'a lot of physical diseases and psychotic illnesses', so that breadth of scope in the citing sentence is not supported by this source. (LLM, conf=0.75)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“only the levels of mono, creatinine, NPAR and CRA were higher than HC group, while levels of platelet, albumin, PAR and PNI were lower than HC group (P < 0.001, respectively).”
§ Albumin and Associated Biomarkers in Severe Neuropsychiatric Disorders: Acute-Phase Schizophrenia and Bipolar Disorder > Results > Comparison Among BD-M, BD-D and HCs
plainstates an associationn = 1,405- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“only the levels of mono, creatinine, NPAR and CRA were higher than HC group, while levels of platelet, albumin, PAR and PNI were lower than HC group (P < 0.001, respectively).”
§ Albumin and Associated Biomarkers in Severe Neuropsychiatric Disorders: Acute-Phase Schizophrenia and Bipolar Disorder > Results > Comparison Among BD-M, BD-D and HCs
plainn = 1,405- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
35 more claims
Create a free account to see all 61 claims and to verify the 20 references still open.
- It may state two separate claims as one. 14
- The quote only partly states this claim. 1
- Probably not a substantial claim. 13
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Research indicates that NLR, MLR, PLR, SII, and SIRI are effective predictors of BD occurrence.”
From Investigation of serum cystatin C levels and their diagnostic value in combination with inflammatory ratios in patients with bipolar disorder (2025) · doi:10.3389/fpsyt.2025.1525091 · cites this paper as [47]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ Albumin and Associated Biomarkers in Severe Neuropsychiatric Disorders: Acute-Phase Schizophrenia and Bipolar Disorder > Results > Comparison Among BD-D, BD-M and SCZ
“while levels of albumin, PAR and PNI were lower than SCZ group”
§ Albumin and Associated Biomarkers in Severe Neuropsychiatric Disorders: Acute-Phase Schizophrenia and Bipolar Disorder > Results > Comparison Among BD-D, BD-M and SCZ
“| Albumin | 43.21±4.06a* | 43.68±3.99a** | 42.99±3.66 | 21.21 | 0.000 |”
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ Albumin and Associated Biomarkers in Severe Neuropsychiatric Disorders: Acute-Phase Schizophrenia and Bipolar Disorder > Results > Comparison Among BD-D, BD-M and SCZ
“the levels of WBC, neutrophil and monocyte are higher, while levels of platelet, albumin and PNI are lower in BD-M group than SCZ group”
§ Albumin and Associated Biomarkers in Severe Neuropsychiatric Disorders: Acute-Phase Schizophrenia and Bipolar Disorder > Results > Comparison Among BD-D, BD-M and SCZ
“| Albumin | 43.21±4.06a* | 43.68±3.99a** | 42.99±3.66 | 21.21 | 0.000 |”
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ Albumin and Associated Biomarkers in Severe Neuropsychiatric Disorders: Acute-Phase Schizophrenia and Bipolar Disorder > Results > Logistic Regression
“NPAR (β = 0.370, P = 0.004), PNI (β = −0.118, P = 0.000) and CRA (β = 1.849, P = 0.000) were independent influencing factors.”
§ Albumin and Associated Biomarkers in Severe Neuropsychiatric Disorders: Acute-Phase Schizophrenia and Bipolar Disorder > Results > Logistic Regression
“| BD | −0.011 | −0.235 | – | – | 0.370 | – |”
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ Albumin and Associated Biomarkers in Severe Neuropsychiatric Disorders: Acute-Phase Schizophrenia and Bipolar Disorder > Results > Comparison Among BD-D, BD-M and SCZ
“the levels of WBC, neutrophil and monocyte are higher, while levels of platelet, albumin and PNI are lower in BD-M group than SCZ group”
§ Albumin and Associated Biomarkers in Severe Neuropsychiatric Disorders: Acute-Phase Schizophrenia and Bipolar Disorder > Results > Comparison Among BD-D, BD-M and SCZ
“| Platelet | 240.23±65.38a* | 234.13±65.56 | 237.53±51.58 | 6.679 | 0.001 |”
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ Albumin and Associated Biomarkers in Severe Neuropsychiatric Disorders: Acute-Phase Schizophrenia and Bipolar Disorder > Results > Comparison Among BD-D, BD-M and SCZ
“In BD-D group, only the levels of creatinine, NPAR and CRA were higher than SCZ group”
§ Albumin and Associated Biomarkers in Severe Neuropsychiatric Disorders: Acute-Phase Schizophrenia and Bipolar Disorder > Results > Comparison Among BD-D, BD-M and SCZ
“| NPAR | 1.36±0.26 | 1.32±0.25a** | 1.36±0.24 | 16.04 | 0.000 |”
1 more finding
Create a free account to see every finding of this check.
Citations
Cites
The role of antioxidants in the chemistry of oxidative stress: A review
Pisoschi, A. M., & Pop, A. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.04.040 · Cited by 2,806
[Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients].
Onodera, T., Goseki, N., & Kosaki, G. (1984) · PubMed · Cited by 1,688
Platelet gene expression and function in patients with COVID-19
Manne, B. K., Denorme, F., Middleton, E. A., Portier, I., Rowley, J. W., Stubben, C., Petrey, A. C., Tolley, N. D., Guo, L., Cody, M., et al. (2020) · Blood · doi:10.1182/blood.2020007214 · Cited by 946
Ritchie, R. F., Palomaki, G. E., Neveux, L. M., Navolotskaia, O., Ledue, T. B., & Craig, W. Y. (1999) · Journal of Clinical Laboratory Analysis · doi:10.1002/(sici)1098-2825(1999)13:6<273::aid-jcla4>3.0.co;2-x · Cited by 270 · cited 1×
“Albumin is a protein with anti-inflammatory effects,(8) which are down-regulated in response in the process of inflammation.(9) Some biomarkers derived from albumin have been proved prognostic and predictive functions in critically”
BackgroundThe microbiome, immunity, and schizophrenia and bipolar disorder.
Dickerson, F., Severance, E., & Yolken, R. (2017) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2016.12.010 · Cited by 268
C-reactive protein is associated with renal function abnormalities in a non-diabetic population
Stuveling, E. M., Hillege, H. L., Bakker, S. J. L., Gans, R. O. B., de Jong, P. E., & de Zeeuw, D. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00762.x · Cited by 234 · cited 1×
“Current evidence in the literature showed that elevated serum creatinine reflects inflammation that alters renal endothelial/vascular function leading to decreased renal function, and worsening kidney function may itself be an inflammation.(16) Studies of somatic diseases suggested that creatinine–albumin ratio (CRA)…”
BackgroundWang, D., Hu, X., Xiao, L., Long, G., Yao, L., Wang, Z., & Zhou, L. (2021) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-019-04492-7 · Cited by 210
The Role of Tryptophan Metabolites in Neuropsychiatric Disorders
Davidson, M., Rashidi, N., Nurgali, K., & Apostolopoulos, V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179968 · Cited by 171 · cited 1×
“Some studies has conducted to detect neurobiological markers in schizophrenia and bipolar disorder, NLR, MLR and SII index were significantly higher in patients with BD than in healthy controls;(17) NLR and neutrophil and platelet counts were found to be higher in the patient with schizophrenia as compared to the heal…”
ResultPogorzelska, K., Krętowska, A., Krawczuk-Rybak, M., & Sawicka-Żukowska, M. (2020) · Advances in Medical Sciences · doi:10.1016/j.advms.2020.05.002 · Cited by 153 · cited 1×
“Platelet played an important role in inflammatory response.(23) Studies have demonstrated that a series of inflammatory conditions, including cancer progression,(12) atherosclerosis(24) and the pathophysiology of COVID-19,(25) can be mediated by platelets.”
BackgroundBasta, G., Chatzianagnostou, K., Paradossi, U., Botto, N., Turco, S. D., Taddei, A., Berti, S. L., & Mazzone, A. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.07.039 · Cited by 116 · cited 1×
“A large number of studies have been performed using PNI as prognosis among patients with inflammation-related disease.(15) Current evidence in the literature showed that elevated serum creatinine reflects inflammation that alters renal endothelial/vascular function leading to decreased renal function, and worsening ki…”
BackgroundInflammation as a treatment target in mood disorders: review
Jones, B. D. M., Daskalakis, Z. J., Carvalho, A. F., Strawbridge, R., Young, A. H., Mulsant, B. H., & Husain, M. I. (2020) · BJPsych Open · doi:10.1192/bjo.2020.43 · Cited by 106 · cited 7×
“Over the last two decades, chronic systemic inflammation and immunity are relevant to the pathophysiology of SCZ 3 and BD. 4 Previous studies demonstrated that multiple pathophysiological biomarkers, which are easily available by use of routine blood examinations, are valuable for the study of inflammatory processes a…”
BackgroundInfluentialFusar-Poli, L., Natale, A., Amerio, A., Cimpoesu, P., Grimaldi Filioli, P., Aguglia, E., Amore, M., Serafini, G., & Aguglia, A. (2021) · Brain Sciences · doi:10.3390/brainsci11010058 · Cited by 93
Mazza, M. G., Tringali, A. G. M., Rossetti, A., Botti, R. E., & Clerici, M. (2019) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2019.02.003 · Cited by 89
Balcioglu, Y. H., & Kirlioglu, S. S. (2020) · Psychiatry Investigation · doi:10.30773/pi.2020.0185 · Cited by 80 · cited 1×
“Previous studies demonstrated that multiple pathophysiological biomarkers, which are easily available by use of routine blood examinations, are valuable for the study of inflammatory processes and immune states in psychiatry.(5,6) However, for complicated diseases, like a lot of physical diseases and psychotic illness…”
BackgroundBeyond Haemostasis and Thrombosis: Platelets in Depression and Its Co-Morbidities
Izzi, B., Tirozzi, A., Cerletti, C., Donati, M. B., de Gaetano, G., Hoylaerts, M. F., Iacoviello, L., & Gialluisi, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228817 · Cited by 73 · cited 1×
“The reason could be related to the fact that platelet can regulate 5-HT(23) which plays a key role in depression episode.(27) PNI calculated peripheral blood lymphocyte count and albumin concentration as an indicator of the inflammatory response(28) and linked nutritional status to immune response for patients.”
BackgroundHigh Neutrophil Percentage-To-Albumin Ratio Can Predict Occurrence of Stroke-Associated Infection
Zhang, H., Wu, T., Tian, X., Lyu, P., Wang, J., & Cao, Y. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.705790 · Cited by 73 · cited 2×
“NPAR is a newly exploited predictor related with systemic inflammation stage in somatic diseases, such as cancer and stroke.(11) Increased neutrophil percentage and decreased albumin levels have been demonstrated in patients with SCZ(5,20) and BD.”
BackgroundPlatelet-to-Albumin Ratio: A Novel IgA Nephropathy Prognosis Predictor
Tan, J., Song, G., Wang, S., Dong, L., Liu, X., Jiang, Z., Qin, A., Tang, Y., & Qin, W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.842362 · Cited by 64
Dadouli, K., Janho, M. B., Hatziefthimiou, A., Voulgaridi, I., Piaha, K., Anagnostopoulos, L., Ntellas, P., Mouchtouri, V. A., Bonotis, K., Christodoulou, N., et al. (2022) · Brain Sciences · doi:10.3390/brainsci12081034 · Cited by 57
Chen, Z., Xie, D., Li, Y., Dai, Z., Xiang, S., Chen, Z., & Zhu, W. (2022) · International Journal of General Medicine · doi:10.2147/ijgm.s323114 · Cited by 56
Bowie, C. R., Best, M. W., Depp, C. A., Mausbach, B. T., Patterson, T. L., Pulver, A. E., & Harvey, P. D. (2018) · Bipolar Disorders · doi:10.1111/bdi.12654 · Cited by 54 · cited 1×
“Introduction Schizophrenia and bipolar disorder are severe neuropsychiatric disorders defined by remarkably heterogeneous clinical symptoms and are high global burden diseases because of multiple and persistent functional impairments including dysfunction in thoughts, perceptions, emotions and behaviour,(1) which shar…”
BackgroundWei, Y., Feng, J., Ma, J., Chen, D., Xu, H., Yin, L., & Chen, J. (2022) · BMC Psychiatry · doi:10.1186/s12888-022-03775-9 · Cited by 48 · cited 2×
“The platelet-to-albumin ratio (PAR) was first proposed to assess cancer prognostic and considered as a biomarker for inflammatory status,(12) which has been shown to be effective in predicting inflammation states of affective disorders in previous study.(13) The prognostic nutritional index (PNI) was a biomarker, whic…”
ResultSelf-citationBartoli, F., Crocamo, C., Dakanalis, A., Brosio, E., Miotto, A., Capuzzi, E., Clerici, M., & Carrà, G. (2016) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2016.09.011 · Cited by 48 · cited 3×
“Our findings were not consistent with previous studies 32,33 in that hypo(manic) phases of BD was associated with more obvious changes in inflammatory process than BD-D, but supports another point of view that heterogeneity existed between BD-D and BD-M.”
ResultPreoperative Platelet to Albumin Ratio Predicts Outcome of Patients with Non-Small-Cell Lung Cancer
Guo, M., Sun, T., Zhao, Z., & Ming, L. (2021) · Annals of Thoracic and Cardiovascular Surgery · doi:10.5761/atcs.oa.20-00090 · Cited by 46 · cited 1×
“Platelet albumin ratio (PAR) is a combined indicator of inflammation and nutritional status and has been shown to be a useful and potentially prognostic biomarker for various cancers.(12) There was limited data about PAR and psychotic disorders.”
BackgroundChen, S., Xia, H. S., Zhu, F., Yin, G. Z., Qian, Z. K., Jiang, C. X., Gu, X. C., Yin, X. Y., Tang, W. J., Zhang, T. H., et al. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.10.012 · Cited by 37
Allostatic load, emotional hyper‐reactivity, and functioning in individuals with bipolar disorder
Dargél, A., Volant, S., Brietzke, E. M., Étain, B., Olié, É., Azorin, J., Gard, S., Bellivier, F., Bougerol, T., Kahn, J., et al. (2020) · Bipolar Disorders · doi:10.1111/bdi.12927 · Cited by 37 · cited 7×
“Over the last two decades, chronic systemic inflammation and immunity are relevant to the pathophysiology of SCZ 3 and BD. 4 Previous studies demonstrated that multiple pathophysiological biomarkers, which are easily available by use of routine blood examinations, are valuable for the study of inflammatory processes a…”
BackgroundInfluentialPrognostic value of the creatinine-albumin ratio in acute pancreatitis debridement
Zhao, Z., Yu, Y., Xie, R., Yang, K., Xu, D., Li, L., Lin, J., Zheng, L., Zhang, C., Xu, X., et al. (2020) · BMC Surgery · doi:10.1186/s12893-020-00991-6 · Cited by 37 · cited 2×
“However, for complicated diseases, like a lot of physical diseases and psychotic illnesses, one single biological marker often could not display satisfactory predictive value, while combined biomarkers can effectively improve the sensitivity of prediction.(7) Along with the finding, combinations of biomarkers have bec…”
BackgroundResultSelf-citationA comparison of inflammatory markers in manic and euthymic states of bipolar disorder
Özdin, S., & Usta, M. B. (2021) · Nordic Journal of Psychiatry · doi:10.1080/08039488.2020.1807048 · Cited by 30 · cited 7×
“Over the last two decades, chronic systemic inflammation and immunity are relevant to the pathophysiology of SCZ 3 and BD. 4 Previous studies demonstrated that multiple pathophysiological biomarkers, which are easily available by use of routine blood examinations, are valuable for the study of inflammatory processes a…”
BackgroundInfluentialLa activación plaquetaria como factor desencadenante de la inflamación y la ateroesclerosis
Reyes‐Maldonado, E., Lezama, R. A., & Custodio-Chablé, S. J. (2020) · Cirugía y Cirujanos · doi:10.24875/ciru.19000725 · Cited by 28
Prognostic impact of nutritional risk assessment in patients with chronic schizophrenia
Tsai, M., Chang, T.-H., & Wu, B. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.04.011 · Cited by 24
Xu, H., Wei, Y., Zheng, L., Zhang, H., Luo, T., Li, H., Ma, J., & Chen, J. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.843985 · Cited by 19 · cited 1×
“Previous studies demonstrated that multiple pathophysiological biomarkers, which are easily available by use of routine blood examinations, are valuable for the study of inflammatory processes and immune states in psychiatry.(5,6) However, for complicated diseases, like a lot of physical diseases and psychotic illness…”
BackgroundSelf-citationThe lipid paradox in neuroprogressive disorders: Causes and consequences
Morris, G., Berk, M., Walder, K., O’Neil, A., Maes, M., & Puri, B. K. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.06.017 · Cited by 17
Creatinine and myoglobin are poor predictors of anaerobic threshold in colorectal cancer and health
Nyasavajjala, S. M., Phillips, B. E., Lund, J. N., & Williams, J. P. (2015) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12020 · Cited by 17 · cited 1×
“Creatinine is not only a metabolite of creatine phosphate as an energy storage but also had distinct effects for systemic inflammatory response(7) and capacity to contribute to the total antioxidant.(30) Previous study(31) showed no difference in creatine levels among major depression disorder, BD-M and BD-D, which ha…”
BackgroundGerçek, H. G., CITIR, B. G., & BUKULME, A. (2023) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.4149/bll_2023_077 · Cited by 16
Research works printed but not linked: 2
- Ritchie, 1999, J Clin Lab Anal, 13, 273, 10.1002/(sici)1098-2825(1999)13:6 · doi:10.1002/(sici)1098-2825(1999)13:6
- Onodera, 1984, Nihon Geka Gakkai Zasshi. Japanese, 85, 1001
Cited by
Xiao, C., Gu, X., Feng, Y., & Shen, J. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1367106 · Cited by 12
Zhang, Z., Huang, Y., Zhou, S., Feng, S., Liu, C., Li, H., Zhang, L., Han, W., & Wu, F. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.12.062 · Cited by 10
Zhou, Y., Zhao, L., Tang, Y., & Qian, S. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-06907-z · Cited by 10
“Previous studies have linked low blood albumin levels to depressive symptoms in patients with different types of psychiatric disorders, including patients with schizophrenia and those who have attempted suicide [20–22].”
Multidimensional Epigenetic Clocks Reveal Physiological System-Specific Aging in SchizophreniaPreprint
Harvanek, Z. M., Sehgal, R., Borrus, D. S., Kasamoto, J., Priyanka, A., Smith, R. C., Corley, M. J., Vinkers, C. H., Boks, M. P., Dwaraka, V. B., et al. (2024) · medRxiv · doi:10.1101/2024.10.28.24316295 · Cited by 8
İmre, O., & Kirkas, A. (2026) · BMC Psychiatry · doi:10.1186/s12888-026-08021-0 · Cited by 6
“Another study including patients with both schizophrenia and bipolar disorder demonstrated reduced PNI levels in both patient groups relative to healthy controls, suggesting a shared immunonutritional impairment across these disorders [32].”
Metadata
- Authors
- Xu, H., Zheng, L., Wang, L., Gao, H., Wei, Y., & Chen, J.
- Affiliations
- Peking University (CN)
- Liaocheng People's Hospital (CN)
- Venue
- Neuropsychiatric Disease and Treatment
- Publisher
- Informa UK Limited
- Published
- 2023-09
- Volume
- Volume 19
- Pages
- 2027-2037
- ISSN
- 1176-6328 (ISSN-L)
- 1178-2021
- PMC
- PMC10544194
- OpenAlex
- W4387138532
- Cited by
- 13
- References
- 33
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 3
- FWCI
- 2.64
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Neuropsychiatric Disease and Treatment (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- albumin, inflammation, schizophrenia, bipolar disorder, manic episodes, depressive episodes, prognostic nutritional index, neutrophil percentage-to-albumin ratio, platelet-to-albumin ratio, biomarkers
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-06, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-06 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.